SCHEMBL6894763

SCHEMBL6894763

CCOC(=O)C=CC(=O)O[Si](C)(C)C

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 5/20 0.59
ATM Q13315 1/20 0.48
MAPT P10636 5/20 0.44
NPSR1 Q6W5P4 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
LMNA P02545 3/20 0.41
HTT P42858 1/20 0.41
MDM2 Q00987 1/20 0.40
ALDH1A1 P00352 2/20 0.40
TTR P02766 1/20 0.39
DPP4 P27487 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9709153 1.00 HCAR2 (0.59) HCAR2ATMMAPTNPSR1CA12
Diethyl Maleate SCHEMBL27966383 0.83 HCAR2 (0.80) HCAR2ATMMAPTNPSR1CA12
SCHEMBL6049197 0.83 HCAR2 (0.45) HCAR2ATMALDH1A1
SCHEMBL9615496 0.83 HCAR2 (0.45) HCAR2ATMALDH1A1
Diethyl Maleate SCHEMBL43033 0.83 HCAR2 (0.80) HCAR2ATMMAPTNPSR1CA12
Diethyl Maleate SCHEMBL42602 0.83 HCAR2 (0.80) HCAR2ATMMAPTNPSR1CA12
Diethyl Maleate SCHEMBL2015896 0.83 HCAR2 (0.80) HCAR2ATMMAPTNPSR1CA12
Diethyl Maleate SCHEMBL60423 0.83 HCAR2 (0.80) HCAR2ATMMAPTNPSR1CA12
Diethyl Maleate SCHEMBL2015895 0.83 HCAR2 (0.80) HCAR2ATMMAPTNPSR1CA12
SCHEMBL16004844 0.83 HCAR2 (0.45) HCAR2ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10316046-B2 Method for producing acyloxysilanes, acyloxysilanes obtained thereby, and use of same NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2019-06-11 US disclosed
US-20180044359-A1 Method for Producing Acyloxysilanes, Acyloxysilanes Obtained Thereby, and Use of Same NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2018-02-15 US disclosed
EP-0405537-B1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives WARNER LAMBERT CO (US) 2004-09-08 EP disclosed
EP-0790289-B1 Polymeric material for liquid crystal/polymer composite film, record display medium, and use thereof DAINIPPON PRINTING CO LTD (JP) 2001-09-05 EP disclosed
US-5851422-A Polymeric material for liquid crystal/polymer composite film, record display medium, and use thereof DAI NIPPON PRINTING CO., LTD. (JP) 1998-12-22 US disclosed
EP-0790289-A1 Polymeric material for liquid crystal/polymer composite film, liquid crystal/polymer composite film, record display medium, and use thereof DAI NIPPON PRINTING CO., LTD. (JP) 1997-08-20 EP disclosed
US-5631281-A COMPOUNDS FOR TREATMENT OF ANXIETY WITH INDOLE AMIDES WARNER-LAMBERT COMPANY (US) 1997-05-20 US disclosed
US-5622983-A ANTIOBESITY AGENTS, ANTIPSYCHOTIC AGENTS, ANTIULCER AGENTS WARNER-LAMBERT COMPANY (US) 1997-04-22 US disclosed
US-5580896-A Treatment of pain and colorectal cancer with dipeptoids of α-substituted Trp-Phe derivatives WARNER-LAMBERT COMPANY (US) 1996-12-03 US disclosed
US-5278316-A Indoles WARNER-LAMBERT COMPANY (US) 1994-01-11 US disclosed
EP-0479910-A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED Trp-Phe- AND PHENETHYLAMINE DERIVATIVES WARNER-LAMBERT COMPANY (US) 1992-04-15 EP disclosed
WO-1991000274-A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED TRP-PHE- AND PHENETHYLAMINE DERIVATIVES WARNER-LAMBERT COMPANY (US) 1991-01-10 WO disclosed
EP-0405537-A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives WARNER-LAMBERT COMPANY (US) 1991-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044359-A1 Method for Producing Acyloxysilanes, Acyloxysilanes Obtained Thereby, and Use of Same COASY, AGPS, CA7 HCAR2 443/4885ATM 2679/4885MAPT 4750/4885
US-10316046-B2 Method for producing acyloxysilanes, acyloxysilanes obtained thereby, and use of same COASY, AGPS, CA7 HCAR2 443/4885ATM 2679/4885MAPT 4750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.